HealthEquity
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of HealthEquity generated cash of $242,826,000, which is more than the previous year. Cash used in financing activities reached the amount of -$47,039,000 last year. Net change in cash is therefore $149,713,000.
Cash Flow
| 2015 | 15.04M | -8.43M | 90.47M |
|---|---|---|---|
| 2016 | 26.54M | -90.55M | 36.64M |
| 2017 | 45.59M | -13.05M | 23.77M |
| 2018 | 81.70M | -36.74M | 14.56M |
| 2019 | 113.42M | 25.65M | 22.92M |
| 2020 | 105.85M | -1.74B | 1.46B |
| 2021 | 181.61M | -96.96M | 52.42M |
| 2022 | 140.99M | -639.24M | 394.86M |
| 2023 | 150.65M | -119.12M | -2.67M |
| 2024 | 242.82M | -46.07M | -47.03M |
HQY Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 254.26M | 225.41M | 328.80M | 191.72M | 361.47M | 199.47M | 139.95M | 83.64M | 111.00M | 13.91M |
Operating activities | ||||||||||
Net income | 55.71M | -26.14M | -44.28M | 8.83M | 39.66M | 73.89M | 47.36M | 26.37M | 16.61M | 10.16M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 153.07M | 161.20M | 137.18M | 115.90M | 55.35M | 18.18M | 15.95M | 13.18M | 8.60M | 5.89M |
Stock-based compensation expense | 77.15M | 62.61M | 52.75M | 42.86M | 39.84M | 21.05M | 14.31M | 8.39M | 5.88M | 2.52M |
| Deferred income tax benefit | 77.15M | 62.61M | 52.75M | 42.86M | 39.84M | 21.05M | 14.31M | 8.39M | 5.88M | 2.52M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -8.05M | -9.57M | -11.20M | -413K | -6.12M | -4.30M | -4.73M | -2.72M | -5.17M | -3.38M |
Inventories | 1 | 0 | 0 | -30.42M | -4.10M | -2.28M | 377K | 28K | 5K | -234K |
Accounts payable | -204K | -26.67M | -2.17M | 30.42M | -3.83M | 863K | -581K | 567K | 1.01M | -1.15M |
Cash generated by operating activities | 242.82M | 150.65M | 140.99M | 181.61M | 105.85M | 113.42M | 81.70M | 45.59M | 26.54M | 15.04M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 128.17M | 0 | -53.84M | -728K | -483K | -379K | -40.79M | -305K |
Investments In Property Plant And Equipment | -1.69M | -119.12M | -137.08M | -96.96M | -42.07M | -15.04M | -33.38M | -12.67M | -49.76M | -8.13M |
Acquisitions Net | 0 | 0 | -504.53M | 0 | -1.64B | 11.17M | -2.88M | 0 | 0 | 0 |
Cash generated by investing activities | -46.07M | -119.12M | -639.24M | -96.96M | -1.74B | 25.65M | -36.74M | -13.05M | -90.55M | -8.43M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 456.64M | 295.34M | 458.49M | 22.92M | 14.56M | 7.14M | 23.49M | 132.58M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -50.34M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -54.37M | -8.75M | -65.04M | -239.06M | -7.81M | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -47.03M | -2.67M | 394.86M | 52.42M | 1.46B | 22.92M | 14.56M | 23.77M | 36.64M | 90.47M |
Net Change In Cash | 149.71M | 28.85M | -103.38M | 137.07M | -169.74M | 162.00M | 59.51M | 56.31M | -27.36M | 97.08M |
Cash at end of period | 403.97M | 254.26M | 225.41M | 328.80M | 191.72M | 361.47M | 199.47M | 139.95M | 83.64M | 111.00M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |